GIA NGUYEN: Open Payments
NPI 1528741691 · GARDEN GROVE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $321 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $62 |
| Ardelyx, Inc. | 2 | $34 |
| Eisai Inc. | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| VIVUS LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: CREON, IBSRELA, Leqembi, JARDIANCE, QSYMIA, Ozempic, FARXIGA.
Industry payments across CA — which companies pay providers there.
